RecruitingNCT06600919
This study is looking at whether a digital support tool can help people with Cervical Surgery, Endonasal Surgery, Otologic Disease, or Oropharyngeal Disease. Participants take part in a digital support tool and complete follow-up assessments.
AnxietyOtherOver 18 Years
- Countries
- France
- Sponsor
- Clinique Saint-Vincent
- Condition
- Anxiety
RecruitingNCT07110896
This study is looking at whether Humiome Post LB (Postbiotic) can help people with Healthy Aging. Participants take part in Humiome Post LB (Postbiotic) and complete follow-up assessments.
AnxietyOtherFrom 50 Years to 75 Years
- Countries
- France, Germany
- Sponsor
- dsm-firmenich Switzerland AG
- Condition
- Anxiety
RecruitingNCT06928740
This study is comparing Music Care® device with Control for people with Low Back Pain or Anxiety. Participants receive Music Care® device or Control and complete study visits and assessments.
AnxietyOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Condition
- Anxiety
RecruitingNCT07424404
This study is looking at care and outcomes for people with Schizophrenia or Autism-Related Irritability. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 5 Years to 17 Years
- Countries
- Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT06036316
This study is looking at care and outcomes for people with Psychosis, Schizophrenia, At-risk Mental State, or Language Disorders. Some participants may receive healthy controls instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 16 Years to 55 Years
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
- Condition
- Schizophrenia
RecruitingNCT05296720
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Controls instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
- Condition
- Schizophrenia
RecruitingNCT06361407
This study is looking at care and outcomes for people with Schizophrenia or Sensory Processing Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
- Condition
- Schizophrenia
RecruitingNCT06585787
This study is looking at how safe and effective KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD is for people with Alzheimer Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT04945278
This study is looking at care and outcomes for people with Psychosis of Childhood Borderline or psychosis. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 15 Years to 25 Years
- Countries
- France
- Sponsor
- University Hospital, Brest
- Condition
- Schizophrenia
RecruitingNCT04370730
This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 7 Years to 20 Years
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Condition
- Schizophrenia
RecruitingNCT07343193
This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT05349513
This study is looking at whether questionnaires and follow-up can help people with With Schizophrenia-like Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Henri Laborit
- Condition
- Schizophrenia
RecruitingNCT02670447
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT07003529
This study is looking at care and outcomes for people with Schizophrenia or Hallucinations, Auditory. Some participants may receive Control Group (SCZ+/AH-) instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Condition
- Schizophrenia
RecruitingNCT07058389
This study is looking at whether a digital support tool can help people with schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT05813457
This study is looking at whether a digital support tool can help people with Psychotic Episode. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 15 Years to 35 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Condition
- Schizophrenia
RecruitingNCT06634641
This study is looking at whether blood test can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Condition
- Schizophrenia
RecruitingNCT04300946
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT03649581
This study is looking at compare two subforms of psychotic disorders that have been clinically distinguished in the 1970s for people with Schizophrenia. Taking part may give some people access to compare the two groups of schizophrenic patients, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT05550155
This study is looking at whether Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment can help people with Schizophrenia or Psychosis. Participants take part in Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- University Hospital, Caen
- Condition
- Schizophrenia
RecruitingNCT05980949
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine, United Kingdom
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT07029581
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 84 Years
- Countries
- Bulgaria, Czech Republic, France, Italy, Serbia, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05511363
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Bulgaria, Croatia, Czech Republic, France, Germany, Italy, Serbia, Slovakia, Spain, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT06159673
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 55 Years to 95 Years
- Countries
- Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05865652
This observational study is following people with With Ultra High Risk of Psychotic Transition to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 15 Years to 25 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Henri Laborit
- Condition
- Schizophrenia